MOVE001 | @sedandubs

A1: Phrophylaxis 
A2: Phrophylaxis, Pt. II 
B: Phrophylaxis, Pt. II (Pharma Remix)

Heavyweight 12"
No Digital

Mastered by Beau @ Ten Eight Seven Mastering

Distributed worldwide via White Peach

#MOVE2DIS

MOVE001 | Sedan - Phrovylaxis / Phrovylaxis, Pt.II / Pharma Remix

Medikamente müssen nicht nur zur Krankheit passen, sondern auch zum Patienten oder zur Patientin – nach diesem Prinzip funktioniert die Präzisionsmedizin, auch personalisierte Medizin genannt. Dank immer genauerer molekularer und genetischer Analysen lassen sich Therapien heute passgenauer abstimmen – oder sogar individuelle Medikamente herstellen. Was durch künstliche Intelligenz noch besser werden kann und was das alles bringt, dazu befragen wir vfa-Forschungssprecher Rolf Hömke.

Präzisionsmedizin – Therapien mit individuell ausgewählten oder hergestellten Medikamenten

This audiobook overview is an accompaniment to the e-book Transforming Pharmaceuticals with XR and Digital Twins

Transforming Pharmaceuticals with XR and Digital Twins

In the twelfth episode of TechMarketView's sustainability technology podcast "Totally Sust", SustainabilityViews Research Director Craig Wentworth talks to Sam Jones (SVP of Health, Life Sciences and Manufacturing for the UK & Ireland at Atos) and Martin Keane (Head of Digital at technology innovation centre CPI) about bringing sustainable manufacturing to pharma through IT/OT digital transformation. 

Tune in to discover how their partnership tackles a range of sustainability challenges – from reducing clinical trial waste through real-time product release, to optimising energy consumption based on grid carbon intensity (leveraging Scotland's abundant wind energy, in particular). Tune in to learn how AI-powered feedback loops can enact changes on the factory floor, and how to overcome cultural barriers in IT/OT convergence.

This is an edited version of the podcast. Subscribers to TechMarketView’s SustainabilityViews research can listen to (and download) the full-length 26-minute version from our website (see https://www.techmarketview.com/videos/totally-sust-12-decarbonising-pharma for more details).


Totally Sust #12: Decarbonising pharma [EDIT]

Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 June 2025. In this episode: Sanofi’s Blueprint buy; AstraZeneca’s breast cancer resistance results at ASCO; BMS and BioNTech’s big bispecific deal; Kymera’s Dupixent in a pill; and Degron’s CEO on pipeline and strategy. 
https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-T5ID4HF465BXFGAH7C6OOSEGTA/

This episode was produced with the help of AI text-to-voice and voice emulation tools.

Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Scrip's Five Must-Know Things - 9 June 2025

On the latest episode of Leaders in Pharma, I'm joined by Dr. Jonathan Loughrey, associate director of physical sciences and isotope chemistry and Terry Ernest, director of manufacturing science and technology at Almac Group, where we will discuss an overview of Almac technologies to support, development and final delivery of client targets with enhanced solubility properties.

Leaders in Pharma: Almac Group

In this first episode of the series, small biotech companies are facing tough times, shrinking funding and uncertain futures. But beneath the surface, quiet forces of innovation and resilience are rising. We explore how these sparks of hope might just light the way to a new breakthrough.

First Sparks: Falling for Innovation in a Harsh Market

fable w/ big pharma prod walronD

The 14 July entry deadline for the Citeline Japan Awards 2025 in Tokyo on 21 October is fast approaching! Join Ian Haydock and Lisa Takagi in this bilingual mini podcast as they outline the event and the various Award categories. (Japanese starts at 2:20.)  

More information on categories, entry criteria, table bookings and sponsorship opportunities here: 
English: https://www.citeline.com/en/awards/citelinejapanawards)
Japanese: https://www.citeline.com/ja-jp/awards/citelinejapanawards)

Citeline Japan Awards 2025 - Entry Deadline Approaching! (Bilingual English/Japanese)

Recent advances in biotechnology have enabled a precision medicine field with great promise
for preventing and treating many diseases, to excel. Termed mRNA-based therapeutics or
vaccines; this field promises great hope to combat a wide range of incurable diseases. Any
functional protein/peptide can be produced in the human body by introducing mRNA as a
vaccine or therapeutic agent. mRNA with programmed production, is more effective, faster in
design and production, as well as more flexible and cost-effective than conventional
approaches that are followed.

mRNA based therapeutics and vaccines- An overview

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

A blend of interviews and analysis from one of the most influential analyst and advisory firms in the UK tech market.

www.techmarketview.com

DDE is constantly working to provide smarter technologies, systems and solutions to healthcare companies. For the last 30 years, our focus has been to develop smarter innovations. Today, DDE houses 350+ engineers, technicians, designers, biotechnologists, researchers and experts working at the intersection of technology and healthcare sciences to solve some of the industry’s toughest problems.

M2DS
Est. 2024
Dubstep label & Sound System

move2dis@gmail.com

A podcast covering the latest news and conversations in life sciences brought to you by the editors of Med-Tech Innovation News, Medical Plastics News and European Pharmaceutical Manufacturer.
Now featuring the FemTech Series!

New tracks tagged #pharma